| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $6.8M | -35.4% |
| SG&A Expense | $5.2M | -14.8% |
| Operating Income | -$12.0M | +27.8% |
| Income Tax | $0 | — |
| Net Income | -$11.6M | +28.7% |
| EPS (Basic) | -$8.56 | -631.6% |
| EPS (Diluted) | -$8.56 | -631.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.9M | +360.3% |
| Current Assets | $12.7M | +277.9% |
| Total Assets | $14.1M | +194.8% |
| Current Liabilities | $2.1M | +22.3% |
| Total Liabilities | $2.2M | +19.3% |
| Stockholders' Equity | $11.9M | +307.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.2M | +39.3% |
| Investing Cash Flow | $0 | -100.0% |
| Financing Cash Flow | $18.6M | +540.1% |